Your browser doesn't support javascript.
loading
Proteomic Screens for Suppressors of Anoikis Identify IL1RAP as a Promising Surface Target in Ewing Sarcoma.
Zhang, Hai-Feng; Hughes, Christopher S; Li, Wei; He, Jian-Zhong; Surdez, Didier; El-Naggar, Amal M; Cheng, Hongwei; Prudova, Anna; Delaidelli, Alberto; Negri, Gian Luca; Li, Xiaojun; Ørum-Madsen, Maj Sofie; Lizardo, Michael M; Oo, Htoo Zarni; Colborne, Shane; Shyp, Taras; Scopim-Ribeiro, Renata; Hammond, Colin A; Dhez, Anne-Chloe; Langman, Sofya; Lim, Jonathan K M; Kung, Sonia H Y; Li, Amy; Steino, Anne; Daugaard, Mads; Parker, Seth J; Geltink, Ramon I Klein; Orentas, Rimas J; Xu, Li-Yan; Morin, Gregg B; Delattre, Olivier; Dimitrov, Dimiter S; Sorensen, Poul H.
Afiliación
  • Zhang HF; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Hughes CS; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Li W; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • He JZ; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Surdez D; Center for Antibody Therapeutics, Division of Infectious Diseases, Department of Medicine, University of Pittsburgh Medical School, Pittsburgh, Pennsylvania.
  • El-Naggar AM; Institute of Oncologic Pathology, Shantou University Medical College, Shantou, Guangdong, China.
  • Cheng H; INSERM U830, Equipe Labellisée LNCC, Diversity and Plasticity of Childhood Tumors Lab, PSL Research University, SIREDO Oncology Centre, Institut Curie Research Centre, 75005 Paris, France.
  • Prudova A; Balgrist University Hospital, University of Zurich, Zurich, Switzerland.
  • Delaidelli A; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Negri GL; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Li X; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Ørum-Madsen MS; Modelling and translation Laboratory, Xinxiang Medical University, Xinxiang, Henan, China.
  • Lizardo MM; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Oo HZ; Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.
  • Colborne S; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Shyp T; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Scopim-Ribeiro R; Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.
  • Hammond CA; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Dhez AC; Vancouver Prostate Centre, Vancouver, British Columbia, Canada.
  • Langman S; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Lim JKM; Vancouver Prostate Centre, Vancouver, British Columbia, Canada.
  • Kung SHY; Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.
  • Li A; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Steino A; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Daugaard M; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Parker SJ; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Geltink RIK; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
  • Orentas RJ; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Xu LY; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Morin GB; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Delattre O; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Dimitrov DS; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Sorensen PH; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
Cancer Discov ; 11(11): 2884-2903, 2021 11.
Article en En | MEDLINE | ID: mdl-34021002
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sarcoma de Ewing / Anoicis / Proteína Accesoria del Receptor de Interleucina-1 Límite: Adult / Child / Humans Idioma: En Revista: Cancer Discov Año: 2021 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sarcoma de Ewing / Anoicis / Proteína Accesoria del Receptor de Interleucina-1 Límite: Adult / Child / Humans Idioma: En Revista: Cancer Discov Año: 2021 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos